Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1953 1
1967 1
1978 1
1980 1
1981 1
1982 2
1983 1
1984 1
1985 1
1986 1
1987 2
1988 1
1989 1
1990 2
1993 4
1994 1
1995 1
1996 4
1997 6
1998 9
1999 7
2000 8
2001 6
2002 3
2003 3
2004 5
2005 6
2006 3
2007 5
2008 9
2009 6
2010 9
2011 6
2012 6
2013 3
2014 3
2015 5
2016 11
2017 6
2018 8
2019 3
2020 7
2021 5
2022 8
2023 9
2024 4
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

186 results

Results by year

Filters applied: . Clear all
Page 1
Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.
Trappe RU, Dierickx D, Zimmermann H, Morschhauser F, Mollee P, Zaucha JM, Dreyling MH, Dührsen U, Reinke P, Verhoef G, Subklewe M, Hüttmann A, Tousseyn T, Salles G, Kliem V, Hauser IA, Tarella C, Van Den Neste E, Gheysens O, Anagnostopoulos I, Leblond V, Riess H, Choquet S. Trappe RU, et al. Among authors: hauser ia. J Clin Oncol. 2017 Feb 10;35(5):536-543. doi: 10.1200/JCO.2016.69.3564. Epub 2016 Dec 19. J Clin Oncol. 2017. PMID: 27992268 Clinical Trial.
Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
Schaier M, Morath C, Wang L, Kleist C, Opelz G, Tran TH, Scherer S, Pham L, Ekpoom N, Süsal C, Ponath G, Kälble F, Speer C, Benning L, Nusshag C, Mahler CF, Pego da Silva L, Sommerer C, Hückelhoven-Krauss A, Czock D, Mehrabi A, Schwab C, Waldherr R, Schnitzler P, Merle U, Schwenger V, Krautter M, Kemmner S, Fischereder M, Stangl M, Hauser IA, Kälsch AI, Krämer BK, Böhmig GA, Müller-Tidow C, Reiser J, Zeier M, Schmitt M, Terness P, Schmitt A, Daniel V. Schaier M, et al. Among authors: hauser ia. Front Immunol. 2023 Jul 11;14:1089664. doi: 10.3389/fimmu.2023.1089664. eCollection 2023. Front Immunol. 2023. PMID: 37483623 Free PMC article. Clinical Trial.
Age-matching in renal transplantation.
Waiser J, Schreiber M, Budde K, Fritsche L, Böhler T, Hauser I, Neumayer HH. Waiser J, et al. Among authors: hauser i. Nephrol Dial Transplant. 2000 May;15(5):696-700. doi: 10.1093/ndt/15.5.696. Nephrol Dial Transplant. 2000. PMID: 10809813
186 results